Skip to main content

previous disabled Page of 3
and
  1. Article

    Open Access

    cGAS-ISG15-RAGE axis reprogram necroptotic microenvironment and promote lymphatic metastasis in head and neck cancer

    Cancer cells frequently evolve necroptotic resistance to overcome various survival stress during tumorigenesis. However, we have previously showed that necroptosis is widespread in head and neck squamous cell ...

    **gyuan Li, Jun Tan, Tao Wang, Shan Yu in Experimental Hematology & Oncology (2024)

  2. No Access

    Article

    Genomic features reveal potential benefit of adding anti-PD-1 immunotherapy to treat non-upper aerodigestive tract natural killer/T-cell lymphoma

    Natural killer/T-cell lymphoma (NKTCL) is a highly heterogeneous disease with a poor prognosis. However, the genomic characteristics and proper treatment strategies for non-upper aerodigestive tract NKTCL (NUA...

    Zegeng Chen, He Huang, Huageng Huang, Le Yu, Huawei Weng, Jian **ao, Liqun Zou in Leukemia (2024)

  3. Article

    Open Access

    Blockade of the lncRNA-DOT1L-LAMP5 axis enhances autophagy and promotes degradation of MLL fusion proteins

    Mixed-lineage leukemia (MLL) fusion gene caused by chromosomal rearrangement is a dominant oncogenic driver in leukemia. Due to having diverse MLL rearrangements and complex characteristics, MLL leukemia treated ...

    Tian-Qi Chen, Heng-**g Huang, Shun-**n Zhu in Experimental Hematology & Oncology (2024)

  4. Article

    Open Access

    Osteosarcoma neutrophil extracellular trap network-associated gene recurrence and metastasis model

    Osteosarcoma (OS) is the most common malignancy in children and adolescents and has a high probability of recurrence and metastasis. A growing number of studies have shown that neutrophil extracellular traps (...

    Hao Tang, Jiang **e, Yu-Xuan Du, Ze-Jiu Tan in Journal of Cancer Research and Clinical On… (2024)

  5. No Access

    Article

    Comparison of different adjuvant therapy regimen efficacies in patients with high risk of recurrence after radical resection of hepatocellular carcinoma

    Hepatocellular carcinoma (HCC) has a high recurrence rate even after radical surgery. Postoperative adjuvant transhepatic arterial chemoembolization (PA-TACE), postoperative adjuvant hepatic arterial infusion ...

    Xu Feng, Guo-Ying Feng, Jie Tao, Yu-Pei Ao in Journal of Cancer Research and Clinical On… (2023)

  6. Article

    Open Access

    Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG study

    Recently, progression-free survival at 24 months (PFS24) was defined as clinically relevant for patients with extranodal NK/T cell lymphoma. Herein, the clinical data from two independent random cohorts (696 p...

    Jia-Ying Li, **ao-Rong Hou, Si-Ye Chen, **n Liu, Qiu-Zi Zhong in Annals of Hematology (2023)

  7. No Access

    Article

    In vitro and in vivo study on the treatment of non-small cell lung cancer with radionuclide labeled PD-L1 nanobody

    Nanobodies have become promising carriers due to excellent in vivo properties. Radiopharmaceutical therapy targeting programmed cell death ligand 1 (PD-L1) is an effective therapeutic strategy. Our study aimed...

    Mengqin Zhu, Jiajia Zhang, Mengdie Yang in Journal of Cancer Research and Clinical On… (2023)

  8. Article

    Open Access

    Inhibition of CDC20 potentiates anti-tumor immunity through facilitating GSDME-mediated pyroptosis in prostate cancer

    Increasing evidence suggests that immunotherapy, especially immune checkpoint inhibitors (ICIs), has the potential to facilitate long-term survival in various cancer besides prostate cancer. Emerging evidence ...

    Fei Wu, Minglei Wang, Tao Zhong, Changyan **ao in Experimental Hematology & Oncology (2023)

  9. No Access

    Article

    The role of systemic inflammatory response index (SIRI) and tumor-infiltrating lymphocytes (TILs) in the prognosis of patients with laryngeal squamous cell carcinoma

    Systemic inflammatory response index (SIRI) values and tumor-infiltrating lymphocytes (TILs) are associated with the prognosis of various tumors. There is minimal evidence of those two as prognostic markers in...

    Tian Wang, Duo Zhang, Di Tang, Yu Heng in Journal of Cancer Research and Clinical On… (2023)

  10. Article

    Open Access

    Prevalence, predictors and management of left atrial appendage thrombogenic milieu in atrial fibrillation with low thromboembolic risk

    The present study aimed to investigate the prevalence, predictors, and management of left atrial appendage (LAA) thrombogenic milieu (TM) identified with transesophageal echocardiography (TEE) in non-valvular ...

    Yu Qiao, Zhen Zhao, **ang Cai, Yulong Guo, Ke Liu, **rui Guo in Thrombosis Journal (2023)

  11. Article

    Open Access

    The development of a cSMART-based integrated model for hepatocellular carcinoma diagnosis

    Hepatocellular carcinoma (HCC) generally arises from a background of liver cirrhosis (LC). Patients with cirrhosis and suspected HCC are recommended to undergo serum biomarker tests and imaging diagnostic eval...

    Tong Wu, Rong Fan, Jian Bai, Zhao Yang, Yun-Song Qian in Journal of Hematology & Oncology (2023)

  12. Article

    Open Access

    Carboplatin and nab-paclitaxel chemotherapy with or without atezolizumab as front-line management for treatment-naïve metastatic nonsquamous non-small cell lung cancer with PD-L1 staining: a retrospective study

    The aim of this retrospective review was to compare the efficacy and safety of the atezolizumab plus carboplatin and nab-paclitaxel regimen versus the carboplatin and nab-paclitaxel regimen as front-line manag...

    Bo Xu, Huihui Cheng, Kunhong Li, Yukai Lv in Journal of Cancer Research and Clinical On… (2022)

  13. Article

    Open Access

    Oral arsenic and retinoic acid for high-risk acute promyelocytic leukemia

    Acute promyelocytic leukemia (APL) has become curable over 95% patients under a complete chemo-free treatment with all-trans retinoic acid (ATRA) and arsenic trioxide in low-risk patients. Minimizing chemother...

    Ya-Fang Ma, Ying Lu, Qian Wu, Yin-Jun Lou, Min Yang in Journal of Hematology & Oncology (2022)

  14. Article

    Open Access

    GD2-specific chimeric antigen receptor-modified T cells for the treatment of refractory and/or recurrent neuroblastoma in pediatric patients

    This study aimed to evaluate the safety and efficacy of chimeric antigen receptor (CAR) disialoganglioside 2 (GD2)-specific (4SCAR-GD2) T cells for treatment of refractory and/or recurrent neuroblastoma (NB) i...

    Lihua Yu, Lulu Huang, Danna Lin in Journal of Cancer Research and Clinical On… (2022)

  15. Article

    Open Access

    Evidence-based expert consensus on the management of primary central nervous system lymphoma in China

    Primary central nervous system lymphoma (PCNSL) is a type of central nervous system restricted non-Hodgkin lymphoma, whose histopathological diagnosis is majorly large B cell lymphoma. To provide specific, evi...

    Tong Chen, Yuanbo Liu, Yang Wang, Qing Chang in Journal of Hematology & Oncology (2022)

  16. No Access

    Article

    Intra- and peritumoral radiomics on assessment of breast cancer molecular subtypes based on mammography and MRI

    This study aimed to investigate the efficacy of digital mammography (DM), digital breast tomosynthesis (DBT), diffusion-weighted (DW) and dynamic contrast-enhanced (DCE) MRI separately and combined in the pred...

    Shuxian Niu, Wenyan Jiang, Nannan Zhao in Journal of Cancer Research and Clinical On… (2022)

  17. Article

    Open Access

    A bispecific CAR-T cell therapy targeting BCMA and CD38 in relapsed or refractory multiple myeloma

    BCMA-specific chimeric antigen receptor-T cells (CAR-Ts) have exhibited remarkable efficacy in refractory or relapsed multiple myeloma (RRMM); however, primary resistance and relapse exist with single-target i...

    Heng Mei, Chenggong Li, Huiwen Jiang, in Journal of Hematology & Oncology (2021)

  18. Article

    Open Access

    Correction to: The lncRNA LAMP5-AS1 drives leukemia cell stemness by directly modulating DOT1L methyltransferase activity in MLL leukemia

    The original article [1] contains an error in Fig. 6b for the image of western blot panels.

    Wen-Tao Wang, Tian-Qi Chen, Zhan-Cheng Zeng, Qi Pan in Journal of Hematology & Oncology (2021)

  19. No Access

    Article

    Risk stratification of postoperative recurrence in hypopharyngeal squamous-cell carcinoma patients with nodal metastasis

    To explore lymph node-related risk factors and investigate the benefit of different adjuvant therapy strategies in hypopharyngeal squamous-cell carcinoma (HPSCC) patients with nodal metastasis (N +).

    Hanqing Lin, Tian Wang, Yu Heng, **aoke Zhu in Journal of Cancer Research and Clinical On… (2021)

  20. Article

    Open Access

    The lncRNA LAMP5-AS1 drives leukemia cell stemness by directly modulating DOT1L methyltransferase activity in MLL leukemia

    Mixed-lineage leukemia (MLL) gene rearrangements trigger aberrant epigenetic modification and gene expression in hematopoietic stem and progenitor cells, which generates one of the most aggressive subtypes of leu...

    Wen-Tao Wang, Tian-Qi Chen, Zhan-Cheng Zeng, Qi Pan in Journal of Hematology & Oncology (2020)

previous disabled Page of 3